BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8065023)

  • 1. [Effective combination therapy by recombinant erythropoietin and cepharanthin in a girl with refractory anemia].
    Kitajima H; Anzai K; Kubo M; Hoshi Y; Akatsuka J
    Rinsho Ketsueki; 1994 Jul; 35(7):694-8. PubMed ID: 8065023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aplastic anemia successfully treated with erythropoietin and rhG-CSF].
    Higashino K; Kito K; Hodohara K; Fujiyama Y; Banba T; Hosoda S
    Rinsho Ketsueki; 1992 Sep; 33(9):1237-41. PubMed ID: 1279235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia].
    Misago M; Mori N; Hoshuyama T; Tsukada J; Morimoto I; Oda S; Chiba S; Eto S
    Rinsho Ketsueki; 1991 Aug; 32(8):912-4. PubMed ID: 1942534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
    Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
    Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aplastic anemia with giant splenomegaly and myelofibrosis successfully treated with antilymphocyte globulin].
    Kaito K; Otsubo H; Ogasawara Y; Sekita T; Saeki A; Nishiwaki K; Masuoka H; Shimada T; Yoshida M; Kobayashi M
    Rinsho Ketsueki; 1995 Aug; 36(8):786-91. PubMed ID: 7563614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sustained long-term complete remission in an elderly aplastic anemia patient after cessation of combined therapy consisting of granulocyte-colony stimulating factor and erythropoietin].
    Yasuyama M; Kawauchi K; Sugiyama H; Ohkawa S
    Rinsho Ketsueki; 2000 Jan; 41(1):42-7. PubMed ID: 10695398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe pancytopenia in old age after 12-month ACE inhibitor therapy].
    Schratzlseer G; Lipp T; Riess G; Antoni D; Delius W
    Dtsch Med Wochenschr; 1994 Jul; 119(30):1029-33. PubMed ID: 7519541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.
    Nawata J; Toyoda Y; Nisihira H; Honda K; Kigasawa H; Nagao T
    Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia.
    Takahashi M; Aoki A; Mito M; Nikkuni K; Ohtsuka T; Saitoh H; Moriyama Y; Shibata A
    Hematol Pathol; 1993; 7(3):153-8. PubMed ID: 8244908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe aplastic anemia remarkably improved by a treatment with antilymphocyte globulin, high-dose methylprednisolone and danazol].
    Miyamura K; Kojima S; Takeyama K; Matsushita T; Minami S; Kodera Y
    Rinsho Ketsueki; 1989 Jan; 30(1):72-7. PubMed ID: 2716202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The successful use of recombinant human erythropoietin therapy to anemia of granular lymphocyte proliferative disorder].
    Suzuki A; Aizawa S; Iwase O; Kuriyama K; Nagasu M; Kawanishi Y; Yaguchi M; Nehashi Y; Nakano M; Yoshikawa O
    Rinsho Ketsueki; 1995 Oct; 36(10):1193-8. PubMed ID: 8531330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initiation of hematopoietic recovery by recombinant human granulocyte-macrophage colony-stimulating factor in a case of severe aplastic anemia induced by gold salt].
    Murai K; Michimata M; Shimosegawa K; Oikawa H; Utsugisawa T; Narigasawa Y; Miyairi Y; Kuriya S
    Rinsho Ketsueki; 1995 Jan; 36(1):23-8. PubMed ID: 7715074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of cepharanthin for chronic idiopathic thrombocytopenic purpura].
    Nakayama S; Matsushita A; Ichiba S; Nagai K
    Rinsho Ketsueki; 1992 Mar; 33(3):408-9. PubMed ID: 1578649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-dose cepharanthin therapy of idiopathic thrombocytopenic purpura].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Rinsho Ketsueki; 1992 Mar; 33(3):405-7. PubMed ID: 1578648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelodysplastic syndromes in two young brothers].
    Yabe H; Matsushita A; Ichiba S; Nagai K; Nakayama S
    Rinsho Ketsueki; 1992 Feb; 33(2):184-8. PubMed ID: 1635166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The 5q-syndrome--report of two cases].
    Koyama A; Shirakawa C; Tatsumi Y; Horiuchi F; Hamazaki H; Fujimoto T; Sato M; Irimajiri K; Horiuchi A
    Rinsho Ketsueki; 1989 May; 30(5):707-12. PubMed ID: 2795884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two patients with aplastic anemia successfully treated with G-CSF and erythropoietin].
    Hanamura A; Ichikawa A; Utsumi M; Hotta T
    Rinsho Ketsueki; 1995 Dec; 36(12):1347-52. PubMed ID: 8587170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplastic anemia successfully treated with rituximab.
    Hansen PB; Lauritzen AM
    Am J Hematol; 2005 Dec; 80(4):292-4. PubMed ID: 16315256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.